FindTrial
Sign In

ADAMTS-13 levels in patients with a history of thrombotic thrombocytopenic purpura.

ADAMTS-13 levels in patients with a history of thrombotic thrombocytopenic purpura. - ADAMTS-13 levels in TTP patients.

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29947
Enrollment
50
Registered
2006-10-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thrombotische thrombocytopenic purpura

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with a history of thrombotic thrombocytopenic purpura. Patients are approched by the

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
End point: determination of the ADAMTS-13 activity in blood and the relation with relapsing TTP.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)